JP MORGAN/CALL/BRISTOL-MYERS SQUIBB/70/0.1/21.06.24

JP MORGAN/CALL/BRISTOL-MYERS SQUIBB/70/0.1/21.06.24 Stock

DE000JQ506G5

Market Closed - Börse Stuttgart 05:22:53 2024-06-11 am EDT
0.002 ^EUR	0.00%

Current month	+100.00%
3 months	-80.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BRISTOL-MYERS SQUIBB COMPANY

Chart JP MORGAN/CALL/BRISTOL-MYERS SQUIBB/70/0.1/21.06.24

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Bristol Myers: FDA approval for treatment	Jun. 14	CF
Bristol-Myers Squibb's Augtyro Gets FDA Accelerated Approval for Treatment of Solid Tumors	Jun. 13	MT
Bristol Myers Squibb's Augtyro Gets FDA Accelerated Approval	Jun. 13	DJ
U.S. Food and Drug Administration Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid Tumors	Jun. 13	BU

More news

Quotes 5-day view

Date	Price	Change
24-06-11	0.002	0.00%

Delayed Quote Börse Stuttgart

Last update June 11, 2024 at 05:22 am EDT

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	BRISTOL-MYERS SQUIBB COMPANY
Issuer	J.P. Morgan
WKN	JQ506G
ISIN	DE000JQ506G5
Date issued	2022-09-23
Strike	70 $
Maturity	2024-06-21 (5 Days)
Parity	10 : 1
Emission price	1.04 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	1.73 €
Lowest since issue	0.001 €
Spread	0.01 €
Spread %	90.91%

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Bristol-Myers Squibb Company

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

41.2 USD

Average target price

53.19 USD

Spread / Average Target

+29.11%

Consensus